GNI Group Ltd. 13D and 13G filings for Gyre Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 5:11 pm Unchanged |
2024-01-22 | 13D | Gyre Therapeutics, Inc. GYRE |
GNI Group Ltd. | 73,313,885 85.340% |
0 (Unchanged) |
Filing |
| 2023-11-27 4:49 pm Unchanged |
2023-11-22 | 13D | Gyre Therapeutics, Inc. GYRE |
GNI Group Ltd. | 73,313,885 85.360% |
0 (Unchanged) |
Filing |
| 2023-11-01 4:58 pm Purchase |
2023-10-30 | 13D | Gyre Therapeutics, Inc. GYRE |
GNI Group Ltd. | 73,313,885 85.360% |
73,313,885 (New Position) |
Filing |